Search

  • Order Status
  • Quick Order
  • Promos

Invitrogen

CYLD Polyclonal Antibody

1 Reference
View all (21) CYLD antibodies

{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}

{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}

{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}

Datasheet
Certificates
Protocols
Questions & Answers
Datasheet
Certificates
Protocols
Questions & Answers
Datasheet
Certificates
Protocols
Questions & Answers
Additional Information:
{{banner.description}}
{{$ctrl.isSkuNotesCollapsed ? 'View more' : 'View less'}}
CYLD Polyclonal Antibody

Product Details

PA1-41097

Applications
Tested Dilution
Publications

Western Blot (WB)

2-4 µg/mL
-

Immunocytochemistry (ICC/IF)

5-10 µg/mL
-

Miscellaneous PubMed (Misc)

-
View 1 publication 1 publication
Product Specifications

Species Reactivity

Human

Published species

Human

Host/Isotype

Rabbit / IgG

Class

Polyclonal

Type

Antibody

Immunogen

A synthetic peptide corresponding to amino acids 32-45 of human CYLD.
View immunogen

Conjugate

Unconjugated Unconjugated Unconjugated

Form

Liquid

Concentration

1.0 mg/mL

Purification

Protein G

Storage buffer

PBS

Contains

0.05% sodium azide

Storage conditions

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Shipping conditions

Ambient (domestic); Wet ice (international)

RRID

AB_2261341

Product Specific Information

This antibody is predicted to react with rat based on sequence homology.

Suggested positive control: Hela whole cell extract.

Immunogen sequence: DKQTQKLLKV PKGS

Target Information

CYLD is a 956 aa, cytoplasmic, deubiquitinating enzyme belonging to the ubiquitin carboxy-terminal hydrolases (UCH) family of proteins with three cytoskeletal-associated protein-glycine-conserved (CAP-GLY) domains, a proline rich region, a SH3 binding domain and a sequence homology to catalytic domain of UCH. CYLD is identified as a tumor suppressor protein affecting the JNK signaling pathway. CYLD is a negative regulator of TRAF2 and NF-kappa-B signaling pathway and is also known to have receptor-dependent role in regulating the I-kappa-B kinase pathway. It also has a deubiquitinating activity that is directed towards non-Lys-48-linked polyubiquitin chains and TRAP1 is a novel substrate for deubiquitination. Mutated CYLD is known to be associated with cylindromatosis, multiple familial trichoepithelioma, and Brooke-Spiegler syndrome.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.

Bioinformatics

Protein Aliases: cyld; cylindromatosis (turban tumor syndrome); Deubiquitinating enzyme CYLD; FLJ20180; FLJ31664; FLJ78684; probable ubiquitin carboxyl-terminal hydrolase CYLD; Ubiquitin carboxyl-terminal hydrolase CYLD; ubiquitin specific peptidase like 2; Ubiquitin thioesterase CYLD; ubiquitin thiolesterase CYLD; Ubiquitin-specific-processing protease CYLD; unnamed protein product

View more View less

Gene Aliases: BRSS; CDMT; CYLD; CYLD1; CYLDI; EAC; FTDALS8; HSPC057; KIAA0849; MFT; MFT1; SBS; TEM; USPL2

View more View less

UniProt ID: (Human) Q9NQC7

View more View less

Entrez Gene ID: (Human) 1540

View more View less

Function(s)
thiol-dependent ubiquitin-specific protease activity protein binding peptidase activity cysteine-type peptidase activity zinc ion binding hydrolase activity protein kinase binding metal ion binding Lys63-specific deubiquitinase activity ubiquitinyl hydrolase activity, acting on linear ubiquitin proline-rich region binding Lys48-specific deubiquitinase activity
Process(es)
immune system process proteolysis I-kappaB kinase/NF-kappaB signaling regulation of mitotic cell cycle regulation of tumor necrosis factor-mediated signaling pathway Wnt signaling pathway protein deubiquitination negative regulation of NF-kappaB transcription factor activity negative regulation of type I interferon production nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway defense response to bacterium positive regulation of I-kappaB kinase/NF-kappaB signaling negative regulation of I-kappaB kinase/NF-kappaB signaling CD4-positive or CD8-positive, alpha-beta T cell lineage commitment innate immune response regulation of B cell differentiation positive regulation of T cell differentiation negative regulation of JNK cascade homeostasis of number of cells regulation of inflammatory response negative regulation of inflammatory response positive regulation of T cell receptor signaling pathway regulation of necroptotic process necroptotic process regulation of microtubule cytoskeleton organization protein K63-linked deubiquitination negative regulation of canonical Wnt signaling pathway ripoptosome assembly involved in necroptotic process negative regulation of NIK/NF-kappaB signaling regulation of cilium assembly negative regulation of p38MAPK cascade positive regulation of cellular protein localization protein linear deubiquitination negative regulation of interleukin-18-mediated signaling pathway positive regulation of extrinsic apoptotic signaling pathway regulation of intrinsic apoptotic signaling pathway
guarantee_icon

Performance Guarantee

If an Invitrogen™ antibody doesn't perform as described on our website or datasheet,we'll replace the product at no cost to you, or provide you with a credit for a future purchase.*

Learn more
help_icon

We're here to help

Get expert recommendations for common problems or connect directly with an on staff expert for technical assistance related to applications, equipment and general product use.

Contact tech support